Hydroxystilbamidine

Drug profile

Key facts

Hydroxystilbamidine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1953. DrugCentral lists 1 molecular target, including Trypsin.

• Approval status: ofm (first approved 1953 by the FDA).
• Molecular targets: Trypsin (1 listed in DrugCentral).
• Molecular formula: C16H16N4O; molecular weight 280.33 g/mol.

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Trypsin	—	unknown	AC50 5.50

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1953-12-22	FDA	—	SANOFI AVENTIS US

Chemical structure

• Molecular formula: C₁₆H₁₆N₄O
• Molecular weight: 280.33 g/mol
• CAS number: 495-99-8
• InChIKey: TUESWZZJYCLFNL-UHFFFAOYSA-N
• PubChem CID: 5284571

NC(=N)C1=CC=C(C=CC2=CC=C(C=C2O)C(N)=N)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Hydroxystilbamidine work?

Its molecular targets in DrugCentral include Trypsin.

When was Hydroxystilbamidine first approved?

Hydroxystilbamidine was first approved by the FDA in 1953.

What is the chemical formula of Hydroxystilbamidine?

Hydroxystilbamidine has the molecular formula C16H16N4O and a molecular weight of 280.33 g/mol.

Sources

• DrugCentral drug card 1398 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1301 — compound record and bioactivity
• PubChem CID 5284571 — chemical identifiers
• DrugBank DB14753 — drug record
• FDA UNII 39J262E49W — substance identity
• DailyMed: FDA labels for Hydroxystilbamidine — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.